small molecule

METROCREAM

METRONIDAZOLE

Loss of exclusivityloss of exclusivity
CompanyGALDERMA LABORATORIES LP

Drug detail

Brand nameMETROCREAM
Active ingredientMETRONIDAZOLE
Strength0.75%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalSeptember 1995
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METROCREAM patent cliff — loss of exclusivity — | CliffBio